SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013596
Filing Date
2020-11-12
Accepted
2020-11-12 07:06:44
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akus-20200930x10q.htm 10-Q 1701501
2 EX-31.1 akus-20200930ex311850295.htm EX-31.1 15417
3 EX-31.2 akus-20200930ex312390b90.htm EX-31.2 15410
4 EX-32.1 akus-20200930ex321794791.htm EX-32.1 13860
  Complete submission text file 0001558370-20-013596.txt   5926529

Data Files

Seq Description Document Type Size
5 EX-101.INS akus-20200930.xml EX-101.INS 1144633
6 EX-101.SCH akus-20200930.xsd EX-101.SCH 36222
7 EX-101.CAL akus-20200930_cal.xml EX-101.CAL 40690
8 EX-101.DEF akus-20200930_def.xml EX-101.DEF 148281
9 EX-101.LAB akus-20200930_lab.xml EX-101.LAB 389518
10 EX-101.PRE akus-20200930_pre.xml EX-101.PRE 297627
Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-245-5715
Akouos, Inc. (Filer) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39343 | Film No.: 201303303
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences